From: Adiponectin complexes composition in Japanese-Brazilians regarding their glucose tolerance status
NGT (n = 27) | DM (n = 26) | P value | |
---|---|---|---|
Age (years) | 54.0 ± 9.2 | 55.3 ± 8.6 | 0.58a |
BMI(kg/m2) | 23.4 ± 2.4 | 25.1 ± 2.4 | 0.015a |
Waist circumference (cm) | 79.4 ± 6.5 | 85.1 ± 7.6 | 0.005a |
Waist-hip ratio | 0.83 ± 0.05 | 0.88 ± 0.07 | 0.005a |
Total cholesterol (mg/dL) | 200.9 ± 39.3 | 209.7 ± 33.4 | 0.384a |
HDL-Cholesterol (mg/dL) | 48.8 ± 14.1 | 48.1 ± 8.4 | 0.809a |
LDL-cholesterol (mg/dL) | 121.7 ± 39.1 | 126.4 ± 33.3 | 0.638a |
Triglycerides (mg/dL) | 132.0 (97.2-171.5) | 227.5 (160.0-380.0) | 0.001b |
Fasting plasma glucose (mg/dL) | 104.0 (100.2-107.7) | 134.5 (127.0-170.0) | <0.001b |
Fasting plasma insulin (uU/mL) | 5.8 ± 2.7 | 9.4 ± 3.3 | <0.001a |
HOMA-IR | 1.39 (0.96-1.75) | 3.01 (2.63-3.83) | <0.001b |
eGFR (mL/min/1.73 m2) | 98.1 ± 37.3 | 97.8 ± 32.8 | 0.97a |
HbA1C (%) | - | 6.2 (5.7-7.1) | - |
Treatment for diabetes (n) | |||
SU | - | 2 | - |
MTF | - | 1 | - |
SU + MTF | - | 1 | - |
SU + INS | - | 1 | - |
Treatment for hypertension (n) | |||
B- blocker | 1 | - | - |
Diuretic | 1 | 1 | - |
ACEi | 1 | 1 | - |
B-blocker + diuretic | 1 | 1 | - |
Treatment for dyslipidemia (n) | |||
fibrate | - | 1 | - |